{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "Specialists told Congress that the way Medicare pays for the drug, used to treat dialysis patients, encourages overuse and raises the risk of heart complications.", "headline": {"main": "Panel Told That Anemia-Drug Payment Method Is Flawed", "print_headline": "Panel Told That Anemia-Drug Payment Method Is Flawed"}, "abstract": null, "print_page": "2", "word_count": "453", "_id": "54a91e107988100cd321d4f3", "snippet": "Specialists told Congress that the way Medicare pays for the drug, used to treat dialysis patients, encourages overuse and raises the risk of heart complications.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2006/12/07/business/07epogen.html", "multimedia": [{"subtype": "xlarge", "url": "images/2006/12/07/business/600_drug.jpg", "height": 280, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2006/12/07/business/600_drug.jpg", "xlargeheight": "280"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2006/12/07/business/75_drug.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2006/12/07/business/75_drug.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Medicare", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Anemia", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Kidneys", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "United States Politics and Government", "is_major": "N", "rank": "6", "name": "subject"}, {"value": "Health Insurance and Managed Care", "is_major": "N", "rank": "7", "name": "subject"}, {"value": "Senate", "is_major": "N", "rank": "8", "name": "organizations"}, {"value": "House of Representatives", "is_major": "N", "rank": "9", "name": "organizations"}, {"value": "Amgen Inc", "is_major": "N", "rank": "10", "name": "organizations"}], "byline": {"person": [], "original": "By REUTERS", "organization": "REUTERS"}, "document_type": "article", "pub_date": "2006-12-07T00:00:00Z", "section_name": "Business Day"}, {"type_of_material": "News", "blog": [], "news_desk": "National", "lead_paragraph": "Health officials reported that antidepressant medications appeared to increase significantly the risk of suicide attempts and related behaviors in adults under 25.", "headline": {"main": "Study Finds Medication Raises Suicide Risks in Young Adults", "print_headline": "Study Finds Medication Raises Suicide Risks in Young Adults"}, "abstract": null, "print_page": "25", "word_count": "630", "_id": "54a913fe7988100cd321d3da", "snippet": "Health officials reported that antidepressant medications appeared to increase significantly the risk of suicide attempts and related behaviors in adults under 25.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2006/12/06/health/06drug.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Mental Health and Disorders", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Antidepressants", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Suicides and Suicide Attempts", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Depression (Mental)", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Food and Drug Administration", "is_major": "N", "rank": "6", "name": "organizations"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Benedict", "lastname": "CAREY"}], "original": "By BENEDICT CAREY"}, "document_type": "article", "pub_date": "2006-12-06T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "In a long-awaited analysis, health officials reported yesterday that antidepressant medications appeared to increase significantly the risk of suicide attempts and related behaviors in adults under 25, while reducing such risks in older people. The analysis, the most comprehensive and rigorous to date, found that suicidal behavior of any kind was rare, and that people taking the medications were no more likely to kill themselves than those taking placebo pills. But adults under 25 taking the drugs were more than twice as likely as those on placebos to report a suicide attempt, or to prepare for one by, say, writing a suicide note.", "headline": {"main": "Study Finds Medication Raises Suicide Risks in Young Adults"}, "abstract": "Food and Drug Administration releases long-awaited analysis showing that antidepressant medications appear to increase significantly risk of suicide in adults under 25, while reducing such risk in older people; finds those under 25 taking antidepressants are more than twice as likely to report suicide attempt or prepare for one; more than dozen drugs are included in study (M)", "print_page": "25", "word_count": 630, "_id": "4fd2724f8eb7c8105d82f0b2", "snippet": "In a long-awaited analysis, health officials reported yesterday that antidepressant medications appeared to increase significantly the risk of suicide attempts and related behaviors in adults under 25, while reducing such risks in older people.     ...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=950CEEDD1631F935A35751C1A9609C8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "CHILDREN AND YOUTH"}, {"name": "subject", "value": "MENTAL HEALTH AND DISORDERS"}, {"name": "subject", "value": "ANTIDEPRESSANTS"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "SUICIDES AND SUICIDE ATTEMPTS"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Benedict", "rank": 1, "lastname": "CAREY"}], "original": "By BENEDICT CAREY"}, "document_type": "article", "pub_date": "2006-12-06T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "The panel will weigh evidence that stents used to treat clogged arteries can cause fatal blood clots, and is expected to recommend stricter regulation of the devices.", "headline": {"main": "Federal Panel to Review Use of Artery Device", "kicker": "Market Place", "print_headline": "Federal Panel to Review Use of Artery Device", "content_kicker": "Market Place"}, "abstract": null, "print_page": "4", "word_count": "1064", "_id": "54a90b367988100cd321d2c0", "snippet": "The panel will weigh evidence that stents used to treat clogged arteries can cause fatal blood clots, and is expected to recommend stricter regulation of the devices.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2006/12/05/health/05place.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Stents (Medical Devices)", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Heart", "is_major": "N", "rank": "11", "name": "subject"}, {"value": "Blood", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Food and Drug Administration", "is_major": "N", "rank": "3", "name": "organizations"}, {"value": "Boston Scientific Corporation", "is_major": "N", "rank": "4", "name": "organizations"}, {"value": "Guidant Corporation", "is_major": "N", "rank": "5", "name": "organizations"}, {"value": "American Heart Assn", "is_major": "N", "rank": "6", "name": "organizations"}, {"value": "Medicine and Health", "is_major": "N", "rank": "7", "name": "subject"}, {"value": "Angioplasty", "is_major": "N", "rank": "8", "name": "subject"}, {"value": "Cholesterol", "is_major": "N", "rank": "9", "name": "subject"}, {"value": "Defibrillators", "is_major": "N", "rank": "10", "name": "subject"}], "byline": {"person": [{"firstname": "Barnaby", "middlename": "J.", "lastname": "FEDER", "rank": 1, "role": "reported", "organization": ""}], "original": "By BARNABY J. FEDER"}, "document_type": "article", "pub_date": "2006-12-05T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "Because of Pfizer\u2019s failed trial, drugs similar to torcetrapib from other companies could face greater scrutiny \u2014 and delays \u2014 in getting to market.", "headline": {"main": "Scrutiny of Other Heart Drugs Could Grow After Failed Trial", "print_headline": "Scrutiny of Other Heart Drugs Could Grow After Failed Trial"}, "abstract": null, "print_page": "21", "word_count": "489", "_id": "54a904c57988100cd321d208", "snippet": "Because of Pfizer\u2019s failed trial, drugs similar to torcetrapib from other companies could face greater scrutiny \u2014 and delays \u2014 in getting to market.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2006/12/04/health/04sidepfizer.html", "multimedia": [], "subsection_name": null, "keywords": [{"rank": "1", "is_major": "N", "value": "Pfizer Inc", "name": "organizations"}, {"rank": "2", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Heart", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Cholesterol", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Tests and Testing", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Food and Drug Administration", "name": "organizations"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Louise", "rank": 1, "lastname": "STORY"}, {"organization": "", "role": "reported", "firstname": "Stephanie", "rank": 2, "lastname": "SAUL"}], "original": "By LOUISE STORY  and STEPHANIE SAUL"}, "document_type": "article", "pub_date": "2006-12-04T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "National", "lead_paragraph": "The decision \u2014 on an experimental drug that appeared to be linked to deaths \u2014 may hurt the company for decades.", "headline": {"main": "Pfizer Ends Studies on Drug for Heart Disease", "print_headline": "Pfizer Ends Studies on Drug For Treating Heart Disease"}, "abstract": null, "print_page": "38", "word_count": "547", "_id": "54a900e77988100cd321d199", "snippet": "The decision \u2014 on an experimental drug that appeared to be linked to deaths \u2014 may hurt the company for decades.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2006/12/03/health/03pfizer.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Pfizer Inc", "is_major": "N", "rank": "1", "name": "organizations"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Heart", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "4", "name": "subject"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Alex", "lastname": "BERENSON"}], "original": "By ALEX BERENSON"}, "document_type": "article", "pub_date": "2006-12-03T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "SundayBusiness", "lead_paragraph": "Doctors try to balance a patient's trust with new technology.", "headline": {"main": "Health Hazard: Computers Spilling Your History", "print_headline": "Health Hazard: Computers Spilling Your History"}, "abstract": null, "print_page": "1", "word_count": "2590", "_id": "54a8f9637988100cd321d0c0", "snippet": "Doctors try to balance a patient's trust with new technology.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2006/12/03/business/yourmoney/03health.html", "multimedia": [{"subtype": "wide", "url": "images/2006/12/02/business/03HEALTH.190.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2006/12/02/business/03HEALTH.190.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2006/12/03/business/03health.1.600.jpg", "height": 300, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2006/12/03/business/03health.1.600.jpg", "xlargeheight": "300"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2006/12/03/business/03health.1.75.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2006/12/03/business/03health.1.75.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": "Your Money", "keywords": [{"value": "Medicine and Health", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Privacy", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Politics and Government", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Identity Fraud", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Health and Human Services Department", "is_major": "N", "rank": "5", "name": "organizations"}, {"value": "Gingrich, Newt", "is_major": "N", "rank": "6", "name": "persons"}, {"value": "Markey, Edward J", "is_major": "N", "rank": "7", "name": "persons"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Milt", "lastname": "FREUDENHEIM"}, {"organization": "", "role": "reported", "rank": 2, "firstname": "Robert", "lastname": "PEAR"}], "original": "By MILT FREUDENHEIM and ROBERT PEAR"}, "document_type": "article", "pub_date": "2006-12-03T00:00:00Z", "section_name": "Business Day"}], "meta": {"hits": 7, "offset": 0, "time": 42}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}